Managing thyrotoxicosis in the acute medical setting.
Acute Med
; 17(1): 44-48, 2018.
Article
de En
| MEDLINE
| ID: mdl-29589605
ABSTRACT
Thyrotoxicosis is common and can present in numerous ways with patients exhibiting a myriad of symptoms and signs. It affects around 1 in 2000 people annually in Europe1. The thyroid gland produces two thyroid hormones - thyroxine (T4) and triiodothyronine (T3). Thyroxine is inactive and is converted by the tissues and organs that need it into tri-iodothyronine. In health, the production of these thyroid hormones is tightly regulated by the secretion of thyroid stimulating hormone (TSH; thyrotropin) from the pituitary gland. The term 'thyrotoxicosis' refers to the clinical manifestations of hyperthyroidism.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Thyréotoxicose
Type d'étude:
Diagnostic_studies
/
Etiology_studies
Limites:
Humans
Langue:
En
Journal:
Acute Med
Année:
2018
Type de document:
Article